Lv5
996 积分 2023-05-29 加入
Development of respiratory allergic diseases according to cow’s milk protein allergy mechanisms
2天前
已完结
Unveiling the effectiveness and safety spectrum of biologic therapies in psoriasis: a three-year real-world analysis
2天前
已完结
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia
2天前
已关闭
Comparison of 11 Formulas and Breastfeeding for Atopic Dermatitis and Growth in Pediatric Cow's Milk Protein Allergy: A Systematic Review and Network Meta‐Analysis of 23 Randomized Controlled Trials
7天前
已完结
Efficacy, tolerability, and safety of Efsubaglutide Alfa in participants with obesity or overweight ( LIGHT 1): A randomized, double‐blind, placebo‐controlled, ascending‐dose phase 2a trial
7天前
已完结
Perioperative management of patients on GLP-1 receptor agonists: Risks, recommendations, and future directions—A narrative review
8天前
已完结
中国老年2型糖尿病防治临床指南(2026年版)
9天前
已完结
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial
17天前
已完结
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
17天前
已完结
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies
21天前
已完结
皖公网安备34019202002308
